SMTI
Sanara Medtech Inc
34.90$
-0.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.1% | -4.0% | +3.5% | +20.7% | -0.5% | +9.4% | +2.5% | -28.0% | +2.6% | -5.0% | -0.2% | |
| – | -1.9% | -9.6% | +21.1% | +53.3% | +4.4% | +10.6% | -8.6% | -7.3% | +7.4% | -7.0% | +3.2% | |
| – | -17.5% | -45.1% | +117.5% | +164.7% | -2.5% | +30.3% | -18.0% | -11.9% | +11.0% | -18.0% | +13.4% | |
| – | -17.5% | -45.1% | +117.5% | +164.7% | -2.5% | +30.3% | -18.0% | -11.9% | +11.0% | -18.0% | +13.4% | |
| – | +13.8% | +8.0% | +15.1% | +15.0% | +11.1% | -12.2% | +0.8% | +0.7% | -0.7% | +13.5% | -7.7% | |
| – | -6.0% | -10.4% | -15.7% | -15.6% | -8.5% | +14.8% | +11.2% | -3.6% | +16.6% | -21.0% | +10.9% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -2.3% | -2.2% | -2.2% | -2.2% | -2.4% | +2.5% | -2.4% | -48.5% | -11.7% | -4.2% | -3.3% | |
| – | -6.7% | -4.7% | +14.6% | +53.5% | +0.2% | +21.4% | +6.1% | +2.5% | +3.2% | -7.1% | -1.7% | |
| – | +4.1% | -7.4% | -9.3% | +24.0% | +6.6% | -13.1% | +12.0% | +16.7% | +7.3% | -26.4% | -8.8% | |
| – | +69.8% | +38.7% | -69.9% | +11.5% | -18.3% | -36.0% | -20.4% | +85.3% | +4.2% | +4.2% | +4.1% | |
| – | -0.1% | -40.5% | -24.8% | +62.0% | +3.3% | +39.7% | -30.5% | -19.9% | +100.4% | -60.6% | +52.1% | |
| – | -3.6% | -3.8% | +63.9% | +109.3% | +2.0% | +41.4% | +1.9% | +2.0% | +2.0% | +0.6% | +0.5% | |
| – | +1.2% | -3.4% | -3.7% | -4.6% | -1.0% | -6.9% | -3.5% | -82.7% | -3.4% | +18.5% | +13.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.4% | -1.4% | +0.6% | +0.6% | +0.2% | +0.5% | +0.5% | +3.8% | -3.6% | +4.2% | -3.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.